300584 海辰藥業
按盤價 
73.200 +9.350 (+14.644%)
73.200 +9.350 (+14.644%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.827 | 4.001 | 3.748 | 3.414 | 35.075 |
| 總資產報酬率 ROA (%) | 1.978 | 2.799 | 2.687 | 2.500 | 25.889 |
| 投入資產回報率 ROIC (%) | 2.149 | 3.027 | 2.904 | 2.674 | 27.395 | 邊際利潤分析 |
| 銷售毛利率 (%) | 85.883 | 83.151 | 81.346 | 75.304 | 81.150 |
| 營業利潤率 (%) | 10.265 | 8.289 | 7.588 | 5.718 | 57.287 |
| 息稅前利潤/營業總收入 (%) | 11.282 | 9.938 | 8.699 | 6.665 | 58.321 |
| 淨利潤/營業總收入 (%) | 9.359 | 7.963 | 7.013 | 6.102 | 49.252 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 128.913 | 121.168 | 112.609 | 125.643 | 7.510 |
| 價值變動淨收益/利潤總額(%) | -3.911 | 0.008 | 0.106 | 3.229 | 92.697 |
| 營業外收支淨額/利潤總額(%) | -1.099 | -1.896 | -4.254 | -4.605 | -0.258 | 償債能力分析 |
| 流動比率 (X) | 0.974 | 1.065 | 0.943 | 1.193 | 1.002 |
| 速動比率 (X) | 0.763 | 0.810 | 0.739 | 0.991 | 0.819 |
| 資產負債率 (%) | 28.878 | 29.113 | 29.908 | 26.537 | 27.153 |
| 帶息債務/全部投入資本 (%) | 22.471 | 22.983 | 22.708 | 18.337 | 18.550 |
| 股東權益/帶息債務 (%) | 340.081 | 329.079 | 333.256 | 433.349 | 416.264 |
| 股東權益/負債合計 (%) | 242.789 | 239.916 | 234.355 | 276.827 | 268.811 |
| 利息保障倍數 (X) | 9.992 | 5.513 | 6.122 | 5.558 | 49.384 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 101.804 | 138.243 | 136.316 | 101.316 | 61.430 |
| 存貨周轉天數 (天) | 337.573 | 353.993 | 271.296 | 165.152 | 209.273 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 05/09/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
